PMID: 2490832May 1, 1989Paper

Changes in hypertension treatment and in congestive heart failure mortality in the United States

Hypertension
S YusufR D Abbott

Abstract

The use of antihypertensive agents has increased in recent years and has been more marked among individuals in older age groups (65-74 years) than in middle-aged groups (45-54 years). Because hypertension is a strong risk factor for the development of congestive heart failure, more common use of antihypertensive agents would be expected to reduce the incidence of congestive heart failure. Examination of the national death statistics reveals decreases in congestive heart failure mortality at younger ages with mortality increases at older ages. The reasons for these divergent trends in congestive heart failure mortality in different ages and the apparent inconsistency with respect to the changes in the use of antihypertensive drugs are explored. We speculate that antihypertensive treatment does not completely prevent congestive heart failure but merely postpones its development by several decades.

References

Nov 1, 1986·British Medical Journal·J Coope, T S Warrender
Jan 1, 1986·Advances in Cardiology·C D Furberg, S Yusuf
Jul 10, 1985·The American Journal of Cardiology·T Killip
Oct 19, 1972·The New England Journal of Medicine·W B KannelM Feinleib
Jul 22, 1974·JAMA : the Journal of the American Medical Association
Mar 1, 1966·Journal of Chronic Diseases·F W Wolff, R D Lindeman
Nov 1, 1980·The American Journal of Medicine·A Helgeland

❮ Previous
Next ❯

Citations

Aug 1, 1992·Journal of the American College of Cardiology·D D SchockenE A Ross
Oct 1, 1993·Journal of the American College of Cardiology·K K HoD Levy
Oct 1, 1993·Journal of the American College of Cardiology·B Pitt
Mar 1, 1995·Journal of the American College of Cardiology·R S McKelvieS Yusuf
Sep 1, 1995·Journal of the American College of Cardiology·P J MatherA A Bove
Feb 24, 2001·The Annals of Thoracic Surgery·M S SlaughterP S Pappas
Nov 1, 1996·Archives of Gerontology and Geriatrics·F RengoUNKNOWN CHF Italian Study Investigators
Dec 29, 2000·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·S K Wattanapitayakul, J A Bauer
Sep 14, 2012·Journal of Human Hypertension·P DeviD Xavier
Feb 1, 1995·Journal of Internal Medicine·H Eriksson
Nov 1, 1996·Heart·M G Nicholls
Jan 29, 2002·European Journal of Heart Failure·Francesco GrigioniBruno Magnani
Sep 6, 2000·Lancet·S MacMahon, B Neal
Nov 10, 2010·Nature Reviews. Cardiology·Anh L BuiGregg C Fonarow
Apr 1, 1997·The American Journal of the Medical Sciences·W D HallE J Roccella
Jul 2, 2010·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·D Hu, D Yu
Mar 5, 2016·Nature Reviews. Cardiology·Boback Ziaeian, Gregg C Fonarow
Feb 11, 2005·European Journal of Heart Failure·Deepak GoyalGregory Y H Lip
Nov 25, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·UNKNOWN Working Party of the International Diabetes Federation (European Region)
Dec 15, 1996·The American Journal of Cardiology·J MathewR Garg
Feb 1, 1996·American Heart Journal·R F Gillum
Oct 1, 1993·American Heart Journal·R F Gillum
Oct 1, 1992·The American Journal of Cardiology·D JohnstoneW Gaasch
Feb 21, 1991·The American Journal of Medicine·N K Hollenberg
Sep 1, 1995·Journal of the American Geriatrics Society·D D Tresch, M F McGough
Sep 1, 1997·Journal of the American Geriatrics Society·D D Tresch

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.